{"url_path":"/sec/pure/8-k/2026-03-17/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-17","source_url":"https://www.sec.gov/Archives/edgar/data/1006028/0001493152-26-010383-index.html","accession_number":"0001493152-26-010383","cik":"0001006028","ticker":"PURE","issuer_name":"PURE BIOSCIENCE, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006028/0001493152-26-010383-index.html","primary_entity_key":"0001006028","primary_entity_name":"PURE BIOSCIENCE, INC."},"word_count":154,"has_tables":true,"body_markdown":"**Item\n9.01. Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits\n\n \n\n \n99.1\n[Press Release, dated March 16, 2026.](ex99-1.htm)\n\n \n104\nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n*\nExhibit\n99.1 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act\nof 1934 or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into any registration\nstatement or other document filed with the Securities and Exchange Commission.\n\n \n\n \n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**PURE\nBIOSCIENCE, INC.**\n\n \n \n \n\nDated:\nMarch 16, 2026\nBy: \n\n*/s/\nRobert F. Bartlett*\n\n \n \nRobert\nF. Bartlett\n\n \n \nChief\nExecutive Officer\n\n \n\n \n\n \n\n \n\n**EXHIBIT\nINDEX**\n\n \n\n**Exhibit\nNumber**\n\n \n**Description**\n\n \n \n \n\n99.1\n \n[Press Release, dated March 16, 2026.](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n** **"}